Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02422576
Other study ID # 14.13.NRC
Secondary ID
Status Completed
Phase N/A
First received March 24, 2015
Last updated October 25, 2017
Start date March 2015
Est. completion date September 11, 2017

Study information

Verified date October 2017
Source Nestlé
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Assessment of the improvement of the safety of the swallowing function under 3 natural ingredients known to be agonist of sensory receptors.


Description:

The trial will be double-blind, randomized, monocentric, and interventional with a hybrid design. The subjects will be randomized to one of the three parallel active ingredient groups. Products will be compared versus control (Thicken Up Clear - nectar viscosity), which adds a part of cross over within the design.

The total sample size is 84 enrolled subjects. Patients will be males and females aged 55+ with mild proven dysphagia.


Recruitment information / eligibility

Status Completed
Enrollment 104
Est. completion date September 11, 2017
Est. primary completion date June 12, 2017
Accepts healthy volunteers No
Gender All
Age group 55 Years and older
Eligibility Inclusion Criteria:

- Patients aged 55+

- Patients showing impaired safety of the deglutition during the V-VST (volume - viscosity swallow test): Cough oxygen desaturation =3% or voice change.

- Neurodegenerative or ischemic/hemorrhagic cerebral cause (stroke) or elderly subjects

Exclusion Criteria:

- Patients radiated for treatment of head and neck cancer Idiosyncrasis

- Allergy to food or medication, especially contrast products (iodine)

- Major respiratory disease needing oxygen as standard treatment.

- Any major and relevant abdominal, head and neck, or chest surgery within the three months preceding the study.

- Have a high alcohol consumption (more than 2 drinks/day)

- Subject who cannot be expected to comply with the study procedures, including consuming the test products.

- Currently participating or having participated in another clinical trial during the month preceding the study

- Patients with relevant mucosal damage or with in-mouth irritation

- Patients with pacemaker or electrode implants

- Epileptic patients

Study Design


Related Conditions & MeSH terms


Intervention

Other:
cinnamon extract
acute exposure to natural ingredient during physiological parameters recording (deglutition or cortical activity)
lemon extract
acute exposure to natural ingredient during physiological parameters recording (deglutition or cortical activity)
lemon extract plus eucalyptus extract
acute exposure to natural ingredient during physiological parameters recording (deglutition or cortical activity)
Thicken Up clear: TUC


Locations

Country Name City State
Spain Hospital de Mataró Mataró Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Nestlé

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Improvement of the safety of the swallowing function, according to Rosenbek's scale The maximum PAS score across the different boluses (5, 10 and 20 ml) during nectar series (with and without active ingredient) assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. up to15 min after ingredient ingestion
Secondary Swallowing safety-Prevalence of penetration the prevalence of penetration in the population according to Rosenbek's PAS (scores of 2-5)
, assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition.
up to15 min after ingredient ingestion
Secondary Swallowing safety-Prevalence of aspiration the prevalence of aspiration in the population according to Rosenbek's PAS (scores of 6-8), assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. up to15 min after ingredient ingestion
Secondary Efficacy of swallowing function-Severity of the amount of oral and pharyngeal residues Severity of the amount of oral and pharyngeal residues, assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. up to15 min after ingredient ingestion
Secondary Efficacy of swallowing function-Prevalence of subjects with oral and pharyngeal residues Prevalence of subjects with oral and pharyngeal residues, assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. up to15 min after ingredient ingestion
Secondary Efficacy of swallowing function-Time to upper oesophageal sphincter opening Time to upper oesophageal sphincter opening, assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. up to15 min after ingredient ingestion
Secondary Efficacy of swallowing function-Time to laryngeal vestibule opening Time to laryngeal vestibule opening, assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. up to15 min after ingredient ingestion
Secondary Efficacy of swallowing function-time to laryngeal vestibule closure time to laryngeal vestibule closure, assessed during videofluoroscopic (VF) recording of radio-opaque bolus deglutition. up to15 min after ingredient ingestion
Secondary Modification of brain physiology response to sensory input: Amplitude and latency of the 4 peaks of the pharyngeal sensory evoked potentials (PSEP) on EEG. up to 20 min after ingredient ingestion
Secondary Tolerability to the products (gastrointestinal comfort) using a questionnaire, assessed during EEG sessions (V3 and V4) to avoid capturing side effects of the contrast agent (as nausea). using questionnaire ponctually at the end of visits V3 and V4, after the EEG recording lasting about 30 min, during wich the product is ingested
Secondary palatability using a questionnaire, assessed during EEG sessions (V3 and V4) using questionnaire ponctually at the end of visits V3 and V4, after the EEG recording lasting about 30 min, during wich the product is ingested
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03711474 - Dysphagia Following Anterior Cervical Spine Surgery; Single Dose Steroid vs Saline (DysDexVSSal) Phase 4
Enrolling by invitation NCT04074356 - Non-invasive Markers of Esophageal Function in Adults N/A
Suspended NCT04349462 - Post Critical Illness Dysphagia in the Intensive Care Unit N/A
Not yet recruiting NCT05982977 - Study on the Effect Mechanism of Acupuncture Combined With Swallowing Training in Oral Dysphagia of Stroke N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Active, not recruiting NCT03455608 - PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer N/A
Active, not recruiting NCT03604822 - Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS N/A
Recruiting NCT03682081 - Interventions for Patients With Alzheimer's Disease and Dysphagia N/A
Completed NCT05700838 - Refining Cough Skill Training in Parkinson's Disease and Dysphagia Phase 1
Not yet recruiting NCT04064333 - Slow-Stream Expiratory Muscle Strength Training for Veterans With Dysphagia Living in Long-term Care N/A
Completed NCT02927691 - Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial Phase 2
Not yet recruiting NCT02724761 - Prophylactic Racemic Epinephrine in Anterior Cervical Discectomy and Fusion N/A
Completed NCT01919112 - Fostering Eating After Stroke With Transcranial Direct Current Stimulation N/A
Completed NCT01370083 - Tongue Pressure Profile Training for Dysphagia Post Stroke Phase 2
Completed NCT01723358 - Neuromuscular Electrical Stimulation (NMES) Treatment Technique Therapy in the Management of Young Infants With Severe Dysphagia Phase 2
Withdrawn NCT01200147 - Effectiveness of Rupture of Schatzki's Ring Using Biopsy Forceps Versus SIngle Dilation N/A
Completed NCT00570557 - Development of a Web-Based Course to Maintain Skills in Nurses Trained to Screen for Dysphagia N/A
Recruiting NCT00166751 - Sonographic Assessment of Laryngeal Elevation N/A
Completed NCT00717028 - Functional Endoscopic Evaluation of Swallowing N/A
Completed NCT01476241 - Percutaneous Endoscopic Gastrostomy Tube Placement by Otorhinolaryngologist N/A